(MENAFN) On Tuesday night, Apr. 13 South Africa's Health Minister Zweli Mkhize declared in a media meeting the voluntary halt of the Johnson & Johnson (J&J ) coronavirus vaccine distribution in the nation.
The conclusion was made after the Food and Drug Administration's (FDA) suggestion to provisionally suspend the J&J vaccine program in the United States, stated Mkhize.
The minister noted: "this has occurred to due reports of 6 females who developed unusual blood clots with low platelets. These incidents occurred between 6 and 13 days after vaccination in women between the ages of 18 and 48 years old."
He added that there is no report of clots that have formed following the immunization in South Africa after the nation vaccinated 289,787 health care workers. Nonetheless, South African scientists have warned that "we cannot take the decision made by the FDA lightly."
MENAFN14042021000045011361ID1101913917
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.